Drug Type Small molecule drug |
Synonyms Mometasone/nortriptyline, Nortriptyline/mometasone, CRX-191 |
Target |
Action agonists, inhibitors |
Mechanism GR agonists(Glucocorticoid receptor agonists), MAO inhibitors(Monoamine oxidase inhibitors) |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H22ClN |
InChIKeySHAYBENGXDALFF-UHFFFAOYSA-N |
CAS Registry894-71-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Psoriasis | Phase 2 | Germany | - | |
| Atrophy | Phase 1 | Germany | 01 Sep 2007 |





